Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

PALONOSETRON HYDROCHLORIDE

PALONOSETRON HYDROCHLORIDE

Standard Dose
0.25MG(BASE)/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview PALONOSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 204731 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient PALONOSETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.25MG(BASE)/5ML Sponsor AKORN INC Submission history Latest submission status date: 2015-11-09 00:00:00.

Structured Monograph

Clinical summary

Approval overview PALONOSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 204731 (ANDA). Marketing status: None (Tentative Approval) Active ingredient PALONOSETRON HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 0.25MG(BASE)/5ML Sponsor AKORN INC Submission history Latest submission status date: 2015-11-09 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.
PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE) | Drug Monograph | MedicHelpline